In the US, among women at high risk for acquiring HIV infection, only around 2% have initiated PrEP. What are the patient, provider, and system barriers to increased PrEP uptake in this vulnerable population? What can clinicians do to overcome these barriers?
In this issue, Dr. Rachel Scott, Scientific Director of Women’s Health Research at the MedStar Health Research Institute and Assistant Professor of Obstetrics and Gynecology at the Georgetown University School of Medicine, provides some answers.
In this ongoing series, Dr. Paul Auwaerter from Johns Hopkins School of Medicine provides a weekly update on COVID-19 and answers your questions. In this episode, he discusses the latest clinical data and answers your questions on topics such as therapeutics, chest X-rays and CTs, immunocompromised patients, & antibody and viral oropharyngeal testing.
Join us in a follow up to last week’s webcast – COVID-19: Keeping Up with a Moving Target and the first of our new coronavirus educational activities as part of DKBmed’s Radio Hour. Today Dr. Auwaerter provides us with updates on infection rates, therapeutics, and testing. Plus, he answers your questions about topics such as proper protective equipment, use of ibuprofen with COVID-19, and pregnancy.
COVID-19 news is changing rapidly and we are all trying to stay on top of the latest medical information from trusted sources. Dr. Paul Auwaerter from Johns Hopkins School of Medicine covers what we know about the coronavirus outbreak in this podcast. Visit https://covid19.dkbmed.com/ for ongoing updates on COVID-19 from trusted medical professionals.
People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health? In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.
Spirometry, FEV1, the FEV1/FVC ratio, the GOLD guidelines — in this case-based podcast, Dr. Emily Brigham from The Johns Hopkins University School of Medicine explains how these elements work together to provide primary care practitioners the information they need to diagnose, manage, and (when necessary) refer their patients with COPD to a pulmonary specialist.
Take our post-test to claim CME credits: https://elit.dkbmed.com/issues/50/test
Read the companion newsletter: https://elit.dkbmed.com/issues/49
In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns Hopkins School of Medicine, analyzed the current research about the potential uses of two-drug ART regimens. Join her now for a case-based discussion about how that new information can affect patient selection in the clinic.
New CFTR modulators for F508del mutations? New research into reducing inflammation in the CF lung? In this issue, Dr. Jennifer Taylor-Cousar from National Jewish Health in Denver explains the potential clinical impact of new and emerging CF disease modifying therapies.